Journal article

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

Abstract:: Background
Controversy exists as to whether the threshold for blood pressure-lowering treatment should differ between people with and without type 2 diabetes. We aimed to investigate the effects of blood pressure-lowering treatment on the risk of major cardiovascular events by type 2 diabetes status, as well as by baseline levels of systolic blood pressure.
Methods
We conducted a one-stage individual participant-level data meta-analysis of major ... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Nazarzadeh, M., Bidel, Z., Canoy, D., Copland, E., Bennett, D. A., Dehghan, A., Davey Smith, G., Holman, R. R., Woodward, M., Gupta, A., Adler, A. I., Wamil, M., Sattar, N., Cushman, W. C., McManus, R. J., Teo, K., Davis, B. R., Chalmers, J., Pepine, C. J., & Rahimi, K. (2022). Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis. The Lancet Diabetes and Endocrinology, 10(9), 645–654.

MLA Style

Nazarzadeh, M., et al. “Blood Pressure-Lowering Treatment for Prevention of Major Cardiovascular Diseases in People with and without Type 2 Diabetes: an Individual Participant-Level Data Meta-Analysis.” The Lancet Diabetes and Endocrinology, vol. 10, no. 9, Elsevier, 2022, pp. 645–54.

Chicago Style

Nazarzadeh, M, Z Bidel, D Canoy, E Copland, DA Bennett, A Dehghan, G Davey Smith, et al. 2022. “Blood Pressure-Lowering Treatment for Prevention of Major Cardiovascular Diseases in People with and without Type 2 Diabetes: an Individual Participant-Level Data Meta-Analysis.” The Lancet Diabetes and Endocrinology 10 (9): 645–54.
Share
Print

Access Document

Files:: Nazarzadeh_et_al_2022_Blood_pressure_lowering.pdf

(Preview, Version of record, pdf, 721.4KB, Terms of use)

Publisher copy:: 10.1016/s2213-8587(22)00172-3

Authors

+ Nazarzadeh, M More by this author

Role:: Author

+ Bidel, Z More by this author

Role:: Author

+ Canoy, D More by this author

Role:: Author

+ Copland, E More by this author

Role:: Author

+ Bennett, DA More by this author

Role:: Author

More authors...

Contributors

+ Blood Pressure Lowering Treatment Trialists' Collaboration

Role:: Contributor

+ National Institute for Health Research More from this funder

Grant:: NIHR200201

Publisher:: Elsevier
Journal:: The Lancet Diabetes and Endocrinology More from this journal
Volume:: 10
Issue:: 9
Pages:: 645-654
Publication date:: 2022-07-22
Acceptance date:: 2022-06-07
DOI:: 10.1016/s2213-8587(22)00172-3
EISSN:: 2213-8595
ISSN:: 2213-8587
Pmid:: 35878651

Language:: English
Keywords:: Blood Pressure Lowering Treatment Trialists' Collaboration

FFR
Pubs id:: 1272183
Local pid:: pubs:1272183
Deposit date:: 2022-08-09

Terms of use

Copyright holder:: Nazarzadeh et al.
Copyright date:: 2022
Rights statement:: ©2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP